Funded Tech Companies
Ensemble Discovery
Wondering who invested in Ensemble Discovery? Flagship Pioneering, Oxford Bioscience Partners and Presidio Partners invested in this biopharmaceutical company.
Company Overview
Company Name
Ensemble Discovery
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
35 Norman St.
Salem, MA 01970
USA
Salem, MA 01970
USA
Phone
Website
Email Address
Company Background Information
Overview
Ensemble is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer and other serious diseases. We are aggressively applying our proprietary drug discovery platform to go beyond the boundaries of traditional therapeutics by developing novel small molecules against challenging disease targets.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/30/2007
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Taylor
Chief Scientific Officer
Nick Terrett
Vice President
Stephen Hale
Vice President
David Livingston
VP - Bus. Development
Ted Hibben
VP - Finance
Andrea Szekely-Hill
Company Investors
- Flagship Pioneering (Noubar Afeyan)
- Oxford Bioscience Partners (Mark Carthy)
- Presidio Partners
- Arch Venture Partners (Robert Nelsen)
- Flagship Pioneering (Douglas Cole)
- Arch Venture Partners (Karen Kerr)
Browse more funded tech companies:
ENSEM Therapeutics | Ensemble Technologies
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs